Premaitha Health (NIPT)

 

NIPT Share PerformanceMore

52 week high14.4000 06/03/17
52 week low6.8500 18/10/17
52 week change -0.5000 (-5.88%)
4 week volume9,252,242 22/10/17

Media for (NIPT)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Grant of Share Options

RNS Number: 9572U Premaitha Health PLC 30 October 2017 Premaitha Health plc ("Premaitha" or the "Company") Grant of share options Manchester, UK - 30 October 2017: Premaitha Health plc (AIM: NIPT), a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT") , announces that it has made a grant of share options. T...

Result of AGM

RNS Number: 4989U Premaitha Health PLC 24 October 2017 Premaitha Health Plc ("Premaitha" or the "Company") Result of AGM Manchester, UK - 24 October 2017 - Premaitha announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed. For more information, please contact: Premaitha Health PLC Dr Stephe...

Premaitha expects dispute ruling by year end

Premaitha Health said it expects an initial ruling in a UK patent dispute litigation by the end of the year. In the meantime, ...

AGM Statement

RNS Number: 3931U Premaitha Health PLC 24 October 2017 Premaitha Health PLC (" Premaitha " or the "Company " or the "Group") AGM Statement Manchester, UK - 24 October 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT"), will be holding its Annual General M...

Premaitha Health expands in Middle East

Premaitha Health has signed contracts with three additional laboratories in the Middle East. It is anticipated thee new labor...

Middle East Update

RNS Number: 4988T Premaitha Health PLC 13 October 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Commercial progress in the Middle East Manchester, UK - 13 October 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), announces further commercial ...

Final Results

RNS Number: 1752S Premaitha Health PLC 29 September 2017 Premaitha Health PLC (" Premaitha, " the "Company" or the "Group") Full year results to 31 March 2017 and half-year trading update Manchester, UK - 29 September 2017: Premaitha ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing ("NIPT"), an...

Notice of AGM

RNS Number: 1743S Premaitha Health PLC 29 September 2017 Premaitha Health PLC Notice of Annual General Meeting Manchester, UK - 29 September 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing, announces that its annual general meeting will be held at 2:00 p.m. on 24 Oct...

Fundamental DataMore

EPS-3
Dividend yield0 %

Latest discussion posts More

  • Breaking out....

    It's been a long time coming but today it seems we are finally breaking out above that downward trendline with the price moving above the 50day EMA. Perhaps the judge and his ...
    6-Nov-2017
    the old trout
  • court case

    when is the news coming from the court case,as the share price looks to be drifting down.
    19-Oct-2017
    caraldo
  • Middle East Expansion

    This can only fly, surely, when the litigation weight is lifted. Allow us to dream, what do others think it will get to when the legal shenanigans are complete. Mr P
    13-Oct-2017
    Mr Papillon

Users' HoldingsMore

Users who hold Premaitha Health also hold..
LLOYDS GRP.19%
ROCKHOPPER18%
GULF KEYSTONE14%
RANGE RES.13%
LENOVO12%

Codes & Symbols

ISINGB00BN31ZD89
SymbolsNIPT, LSE:NIPT, NIPT.L, NIPT:LN, LON:NIPT, XLON:NIPT

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account